Literature DB >> 34580902

Endoplasmic reticulum stress promotes HBV production by enhancing use of the autophagosome/multivesicular body axis.

Xueyu Wang1,2, Zhiqiang Wei2,3, Bin Cheng3, Jia Li2, Yulin He3, Tingyu Lan3, Thekla Kemper2, Yong Lin4, Bin Jiang3,5, Yongfang Jiang1, Zhongji Meng3,6, Mengji Lu2.   

Abstract

BACKGROUND AND AIMS: HBV infection has been reported to trigger endoplasmic reticulum (ER) stress and initiate autophagy. However, how ER stress and autophagy influence HBV production remains elusive. Here, we studied the effect of tunicamycin (TM), an N-glycosylation inhibitor and ER stress inducer, on HBV replication and secretion and examined the underlying mechanisms. APPROACH AND
RESULTS: Protein disulfide isomerase (an ER marker), microtubule-associated protein 1 light chain 3 beta (an autophagosome [AP] marker), and sequestosome-1 (a typical cargo for autophagic degradation) expression were tested in liver tissues of patients with chronic HBV infection and hepatoma cell lines. The role of TM treatment in HBV production and trafficking was examined in hepatoma cell lines. TM treatment that mimics HBV infection triggered ER stress and increased AP formation, resulting in enhanced HBV replication and secretion of subviral particles (SVPs) and naked capsids. Additionally, TM reduced the number of early endosomes and HBsAg localization in this compartment, causing HBsAg/SVPs to accumulate in the ER. Thus, TM-induced AP formation serves as an alternative pathway for HBsAg/SVP trafficking. Importantly, TM inhibited AP-lysosome fusion, accompanied by enhanced AP/late endosome (LE)/multivesicular body fusion, to release HBsAg/SVPs through, or along with, exosome release. Notably, TM treatment inhibited HBsAg glycosylation, resulting in impairment of HBV virions' envelopment and secretion, but it was not critical for HBsAg/SVP trafficking in our cell systems.
CONCLUSIONS: TM-induced ER stress and autophagic flux promoted HBV replication and the release of SVPs and naked capsids through the AP-LE/MVB axis.
© 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34580902     DOI: 10.1002/hep.32178

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

1.  Unraveling the Dynamic Role of Microtubules in the HBV Life Cycle.

Authors:  Urania Georgopoulou; John Koskinas
Journal:  J Clin Transl Hepatol       Date:  2022-05-12

2.  Nascent Glycoproteome Reveals That N-Linked Glycosylation Inhibitor-1 Suppresses Expression of Glycosylated Lysosome-Associated Membrane Protein-2.

Authors:  Xinyi Cao; Peiyi Meng; Yuyin Shao; Guoquan Yan; Jun Yao; Xinwen Zhou; Chao Liu; Lei Zhang; Hong Shu; Haojie Lu
Journal:  Front Mol Biosci       Date:  2022-04-27

Review 3.  HBV cccDNA-A Culprit and Stumbling Block for the Hepatitis B Virus Infection: Its Presence in Hepatocytes Perplexed the Possible Mission for a Functional Cure.

Authors:  Sajad Ahmad Bhat; Syed Naqui Kazim
Journal:  ACS Omega       Date:  2022-07-07

Review 4.  Interactions between endoplasmic reticulum stress and extracellular vesicles in multiple diseases.

Authors:  Jingyao Ye; Xuehong Liu
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.